<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30027004</PMID>        <DateRevised>            <Year>2018</Year>            <Month>07</Month>            <Day>24</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Print">2168-8184</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <Issue>5</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>May</Month>                        <Day>12</Day>                    </PubDate>                </JournalIssue>                <Title>Cureus</Title>                <ISOAbbreviation>Cureus</ISOAbbreviation>            </Journal>            <ArticleTitle>Factors Associated with Functional Decline in Elderly Female Breast Cancer Patients in Appalachia.</ArticleTitle>            <Pagination>                <MedlinePgn>e2612</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.2612</ELocationID>            <Abstract>                <AbstractText>Background Functional status has been previously shown in the elderly cancer population to predict both mortality as well as treatment tolerance. The goal of this study was to determine if there are certain subsets of the elderly breast cancer population that are at higher risk of experiencing functional decline following treatment. Methods Patient charts from the Edwards Comprehensive Cancer Center in Huntington, West Virginia, from January 2006 - January 2016 were reviewed. Relevant inclusion criteria included patients of 65 years of age and older with a new diagnosis of Stage 0-III breast cancer. Functional decline was defined as an increase of at least one point in Eastern Cooperative Oncology Group (ECOG) scores within one year of diagnosis. ECOG performance status was subjectively determined by the physician. Fisher's exact test and Pearson's Chi-squared test were initially utilized to assess potential factors associated with functional decline such as pretreatment ECOG score, age at diagnosis, stage, hormone receptor status, type of surgery received, whether radiation therapy, chemotherapy, or hormonal therapy was received, medical comorbidities, body mass index (BMI), complaints of weakness at diagnosis, and ambulatory status. Factors that were found to be significant were further assessed via multivariate logistic regressions. Results Three-hundred and fourteen patients were identified as meeting inclusion criteria. At one-year follow-up, 45 patients (14.3% of the cohort) had documented functional decline. On initial analysis, factors associated with functional decline included Stage III disease (p=0.002) and complaints of weakness at diagnosis (p=0.004). Following multivariate analysis, Stage III disease (p = 0.02), complaints of weakness at diagnosis (p = 0.04), and bilateral mastectomy (p = 0.03) were significantly associated with functional decline. Conclusion Patients who were diagnosed with Stage III breast cancer, had complaints of weakness at time of diagnosis, or had bilateral mastectomies were more likely to have a decline in functional status at one-year follow-up. Awareness of factors associated with functional decline in the elderly Appalachian population with Stage 0-III breast cancer will be useful during discussions regarding patient expectations, treatment, and goals of care. Elderly breast cancer patients for whom bilateral prophylactic mastectomies are not indicated may be better served by lumpectomy alone (based on patient age, hormone receptor status, and tumor size), lumpectomy followed by radiation therapy, or unilateral mastectomy to maximize the likelihood of functional preservation following treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Singh</LastName>                    <ForeName>Raj</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ansinelli</LastName>                    <ForeName>Hayden</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, University of Arizona College of Medicine, Tucson, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Katz</LastName>                    <ForeName>Heather</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Hematology/oncology, Marshall University, Joan C. Edwards School of Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jafri</LastName>                    <ForeName>Hassaan</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Internal Medicine, Marshall University, Joan C. Edwards School of Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gress</LastName>                    <ForeName>Todd</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Internal Medicine, Marshall University, Joan C. Edwards School of Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tirona</LastName>                    <ForeName>Maria T</ForeName>                    <Initials>MT</Initials>                    <AffiliationInfo>                        <Affiliation>Director of Medical Oncology, Marshall University, Joan C. Edwards School of Medicine.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>05</Month>                <Day>12</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cureus</MedlineTA>            <NlmUniqueID>101596737</NlmUniqueID>            <ISSNLinking>2168-8184</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Geriatr Oncol. 2017 May;8(3):196-205</RefSource>                <PMID Version="1">28330581</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2018 Jan;68(1):7-30</RefSource>                <PMID Version="1">29313949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Rural Health. 2017 Sep;33(4):375-381</RefSource>                <PMID Version="1">27602545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Nurs. 2010 May;19(9-10):1219-25</RefSource>                <PMID Version="1">20345834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nurs Res. 1994 Jul-Aug;43(4):196-202</RefSource>                <PMID Version="1">8047422</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Serv Res. 2014 Apr;49(2):546-67</RefSource>                <PMID Version="1">24117371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Crit Rev Oncol Hematol. 2011 May;78(2):127-37</RefSource>                <PMID Version="1">20403706</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1993 Apr;67(4):773-5</RefSource>                <PMID Version="1">8471434</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Aug 15;122(16):2579-86</RefSource>                <PMID Version="1">27348765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1996 Jun;32A(7):1135-41</RefSource>                <PMID Version="1">8758243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>W V Med J. 2016 May-Jun;112(3):76-82</RefSource>                <PMID Version="1">27301159</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gerontol. 1993 May;48(3):S94-101</RefSource>                <PMID Version="1">8482831</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">appalachia</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">elderly</Keyword>            <Keyword MajorTopicYN="N">functional decline</Keyword>        </KeywordList>        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30027004</ArticleId>            <ArticleId IdType="doi">10.7759/cureus.2612</ArticleId>            <ArticleId IdType="pmc">PMC6044479</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>